Regulatory agencies like the FDA and EMA evaluate data from clinical trials to ensure that a drug is safe and effective for its intended use. They also inspect manufacturing facilities to confirm that they comply with good manufacturing practices (GMP). These agencies have the authority to approve or reject a new drug application (NDA) or biologics license application (BLA).
